Wisconsin Senator Melissa Agard wants to finally legalize marijuana in Wisconsin.
PharmaCann Planning IPO with Potential Valuation of $1B+
New York-based cannabis firm PharmaCann is planning an initial public offering that could value the company at over $1 billion, according to a Reuters report citing sources familiar with the plan.
Price gains for gold, silver as bulls regain some footing
(Kitco News) - Gold and silver prices are moderately higher in early U.S. trading Friday.
Gold trades near steady as bulls stabilize market
(Kitco News) - Gold prices are trading near steady in midday U.S. dealings Thursday. Importantly, gold bulls have stabilized the market following recent selling pressure that drove prices to a more-than-four-month low on Monday. Silver bulls still have some more work to do to steady their market. October gold futures were last down $0.70 at $1,750.60 and September Comex silver was last down $0.323 at $23.16 an ounce.
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline
MindMed reports a Q2 2021 loss of $36 million. Current cash on hand of $157 million.
Gold price rebounds on signs of peaking US inflation
Gold prices rebounded after the latest US inflation data, easing fears that the Federal Reserve may taper its economic support sooner than expected.
Gold and silver thrive in high-debt environments
Historical charts have shown that every time yields fall below the rate of inflation, ie. they turn negative, gold goes up.
Cannabis Research Provisions Included in Senate-Approved Infrastructure Bill
Included in the $1.2 trillion infrastructure bill are provisions that would let researchers study cannabis from state-licensed dispensaries instead of the low-grade cannabis grown at government facilities.
These States Could Have Marijuana And Psychedelics Legalization On The Ballot In 2022
Marijuana reform has advanced in numerous state legislatures in the first half of 2021, with lawmakers enacting four new legalization laws so far this year.
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
ATAI's newest research partner, Revixia Life Sciences, is seeking to treat depression and substance abuse with Salvinorin A, a lesser-known psychedelic used by indigenous peoples.
Is Access To Psychedelic Medicine The Largest Human Rights Issue Today?
The Mental Health Crisis is now a mental health pandemic. Is access to psychedelic medicine the world's largest human rights issue?
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
Wesana Health announces the commencement of pre-clinical psychedelics research for Traumatic Brain Injury.
